DK0804246T3 - Mitomycinholdige lægemiddelleveringssystemer - Google Patents
Mitomycinholdige lægemiddelleveringssystemerInfo
- Publication number
- DK0804246T3 DK0804246T3 DK94923825T DK94923825T DK0804246T3 DK 0804246 T3 DK0804246 T3 DK 0804246T3 DK 94923825 T DK94923825 T DK 94923825T DK 94923825 T DK94923825 T DK 94923825T DK 0804246 T3 DK0804246 T3 DK 0804246T3
- Authority
- DK
- Denmark
- Prior art keywords
- mmc
- pct
- groups
- carrier polymer
- spacer
- Prior art date
Links
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 title abstract 6
- 229930192392 Mitomycin Natural products 0.000 title abstract 5
- 229960004857 mitomycin Drugs 0.000 title abstract 5
- 238000012377 drug delivery Methods 0.000 title 1
- 125000003277 amino group Chemical group 0.000 abstract 3
- 229920000642 polymer Polymers 0.000 abstract 3
- 230000008878 coupling Effects 0.000 abstract 2
- 238000010168 coupling process Methods 0.000 abstract 2
- 238000005859 coupling reaction Methods 0.000 abstract 2
- 125000006850 spacer group Chemical group 0.000 abstract 2
- 230000003213 activating effect Effects 0.000 abstract 1
- 125000004069 aziridinyl group Chemical group 0.000 abstract 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9317213A GB2282384B8 (en) | 1993-08-18 | 1993-08-18 | Drug delivery agents incorporating mitomycin |
| PCT/IB1994/000259 WO1995005200A1 (en) | 1993-08-18 | 1994-08-17 | Drug delivery agents incorporating mitomycin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0804246T3 true DK0804246T3 (da) | 2000-11-13 |
Family
ID=10740702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94923825T DK0804246T3 (da) | 1993-08-18 | 1994-08-17 | Mitomycinholdige lægemiddelleveringssystemer |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5738864A (da) |
| EP (1) | EP0804246B1 (da) |
| JP (1) | JPH09501674A (da) |
| AT (1) | ATE192933T1 (da) |
| CA (1) | CA2168007C (da) |
| DE (1) | DE69424577T2 (da) |
| DK (1) | DK0804246T3 (da) |
| ES (1) | ES2145832T3 (da) |
| GB (1) | GB2282384B8 (da) |
| GR (1) | GR3034174T3 (da) |
| PT (1) | PT804246E (da) |
| WO (1) | WO1995005200A1 (da) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5850855A (en) * | 1990-01-09 | 1998-12-22 | Ems-Inventa Ag | Flexible coolant conduit and method of making same |
| US6143909A (en) * | 1997-02-26 | 2000-11-07 | Eli Lilly And Company | Selective epoxidation process for preparing pharmaceutical compounds |
| US6251866B1 (en) | 1997-08-05 | 2001-06-26 | Watson Laboratories, Inc. | Conjugates targeted to the interleukin-2 receptor |
| US6958148B1 (en) | 1998-01-20 | 2005-10-25 | Pericor Science, Inc. | Linkage of agents to body tissue using microparticles and transglutaminase |
| US6919076B1 (en) | 1998-01-20 | 2005-07-19 | Pericor Science, Inc. | Conjugates of agents and transglutaminase substrate linking molecules |
| EP1619210A1 (en) * | 1998-10-30 | 2006-01-25 | Daiichi Pharmaceutical Co., Ltd. | DDS compounds and method for assaying the same |
| DE60131177T2 (de) | 2000-09-06 | 2008-08-07 | AP Pharma, Inc., Redwood | Abbaubare polyacetal-polymere |
| WO2003017938A2 (en) * | 2001-08-22 | 2003-03-06 | Watson Pharmaceuticals, Inc. | Conjugates targeted to target receptors |
| US7833545B2 (en) * | 2003-04-29 | 2010-11-16 | The General Hospital Corporation | Methods and devices for the sustained release of multiple drugs |
| US8614228B2 (en) | 2004-08-11 | 2013-12-24 | Arqule, Inc. | Quinone prodrug compositions and methods of use |
| CA2583700A1 (en) | 2004-08-11 | 2006-02-23 | Arqule, Inc. | Quinone prodrug compositions and methods of use |
| EP2077290B1 (en) * | 2005-12-05 | 2010-04-21 | Nitto Denko Corporation | Polyglutamate-amino acid conjugates and methods |
| US20080181852A1 (en) * | 2007-01-29 | 2008-07-31 | Nitto Denko Corporation | Multi-functional Drug Carriers |
| JP5286822B2 (ja) * | 2007-02-22 | 2013-09-11 | Ｊｓｒ株式会社 | ポリアミノ酸またはポリアミノ酸系共重合体の製造方法 |
| JP2010526159A (ja) * | 2007-04-10 | 2010-07-29 | 日東電工株式会社 | 多機能性ポリグルタミン酸塩薬物担体 |
| US7790765B2 (en) | 2007-04-30 | 2010-09-07 | Arqule, Inc. | Hydroxy sulfonate of quinone compounds and their uses |
| ES2430380T3 (es) * | 2007-05-09 | 2013-11-20 | Nitto Denko Corporation | Composiciones que incluyen un compuesto hidrófobo y un conjugado de poliaminoácido |
| EP2155253A2 (en) * | 2007-05-09 | 2010-02-24 | Nitto Denko Corporation | Polyglutamate conjugates and polyglutamate-amino acid conjugates having a plurality of drugs |
| CN101730549B (zh) * | 2007-05-09 | 2015-12-09 | 日东电工株式会社 | 与铂类药物结合的聚合物 |
| WO2009111271A1 (en) * | 2008-03-06 | 2009-09-11 | Nitto Denko Corporation | Polymer paclitaxel conjugates and methods for treating cancer |
| US20200164078A1 (en) * | 2017-07-17 | 2020-05-28 | Technische Universiteit Eindhoven | Applicable chemical composition comprising an agent conjugated to a hydrophobic moiety and a carrier |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1541436A (en) * | 1976-02-02 | 1979-02-28 | Searle & Co | Immunological materials |
| JP2528477B2 (ja) * | 1987-09-07 | 1996-08-28 | 三共株式会社 | 高分子制癌剤の増強剤 |
| WO1990001931A1 (en) * | 1988-08-23 | 1990-03-08 | Georgetown University | Mitomycin derivatives having reduced bone marrow toxicity, processes for their preparation, and the uses thereof |
| JPH0762049B2 (ja) * | 1991-03-18 | 1995-07-05 | 工業技術院長 | 高分子マイトマイシンｃ誘導体及びその製造方法 |
| JPH05252673A (ja) * | 1992-03-05 | 1993-09-28 | Honda Motor Co Ltd | 電源装置 |
-
1993
- 1993-08-18 GB GB9317213A patent/GB2282384B8/en not_active Expired - Fee Related
-
1994
- 1994-08-17 PT PT94923825T patent/PT804246E/pt unknown
- 1994-08-17 AT AT94923825T patent/ATE192933T1/de not_active IP Right Cessation
- 1994-08-17 ES ES94923825T patent/ES2145832T3/es not_active Expired - Lifetime
- 1994-08-17 CA CA002168007A patent/CA2168007C/en not_active Expired - Fee Related
- 1994-08-17 DE DE69424577T patent/DE69424577T2/de not_active Expired - Fee Related
- 1994-08-17 EP EP94923825A patent/EP0804246B1/en not_active Expired - Lifetime
- 1994-08-17 WO PCT/IB1994/000259 patent/WO1995005200A1/en not_active Ceased
- 1994-08-17 DK DK94923825T patent/DK0804246T3/da active
- 1994-08-17 US US08/602,733 patent/US5738864A/en not_active Expired - Fee Related
- 1994-08-17 JP JP7506852A patent/JPH09501674A/ja active Pending
-
2000
- 2000-08-10 GR GR20000401869T patent/GR3034174T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69424577D1 (de) | 2000-06-21 |
| EP0804246B1 (en) | 2000-05-17 |
| US5738864A (en) | 1998-04-14 |
| GB2282384B8 (en) | 1997-09-04 |
| DE69424577T2 (de) | 2001-02-22 |
| PT804246E (pt) | 2000-08-31 |
| JPH09501674A (ja) | 1997-02-18 |
| GB2282384A (en) | 1995-04-05 |
| CA2168007C (en) | 2001-06-12 |
| CA2168007A1 (en) | 1995-02-23 |
| GB2282384B (en) | 1997-09-03 |
| ATE192933T1 (de) | 2000-06-15 |
| WO1995005200A1 (en) | 1995-02-23 |
| EP0804246A1 (en) | 1997-11-05 |
| ES2145832T3 (es) | 2000-07-16 |
| GR3034174T3 (en) | 2000-11-30 |
| GB9317213D0 (en) | 1993-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE192933T1 (de) | Mitomycin enthaltende arzneimittelabgabesysteme | |
| CA2187346C (en) | Receptor modulating agents and methods relating thereto | |
| DE69331149D1 (de) | Gerät zum injizieren eines pharmazeutischen präparats in festem zustand | |
| GEP20012413B (en) | Novel Substituted Cyclic Amino Acids as Pharmaceutical Agents | |
| DK1028707T3 (da) | Oftalmiske præparater med forlænget frigivelse og indeholdende vandopløselige medikamenter | |
| CA2159452A1 (en) | Needleless Syringe Using Supersonic Gas Flow for Particle Delivery | |
| BR9406893A (pt) | Emprego de nona- e decapeptideos para a preparação de um medicamento para o combate da aids | |
| GEP20022788B (en) | Pharmaceutical Compositions Having Appetite Suppressant Activity | |
| ID28003A (id) | Turunan-turunan adamantana | |
| ATE316794T1 (de) | Pharmazeutische zusammensetzungen enthaltend lysostaphin allein oder in kombination mit einem antibiotikum zur behandlung von staphylokokkeninfektionen | |
| GEP20012439B (en) | Aniline Derivatives Having Nitrogen Monoxide Synthase Inhibitory Activity and Pharmaceutical Compositions Containing the Same | |
| AU2672995A (en) | {a}-annelated pyrrole derivatives and pharmaceutical uses thereof | |
| GEP20032896B (en) | 4-Aminothiazole Derivatives, Containing Them Pharmaceutical Compositions Inhibiting Cyclin-Dependent Kinases and Methods for Treatment | |
| UY24512A1 (es) | Desnaturalizantes de sales de amina simpatomimeticas | |
| AU4049399A (en) | Novel use of hiv protease inhibiting compounds | |
| KR910002899A (ko) | 혈조절 펩타이드 | |
| YU36401A (sh) | Farmaceutska kompozicija za stimulator osetljivosti na insulin sa modifikovanim ispuštanjem | |
| ID23424A (id) | Glikokonjugat dari 20(s)-kamptotesin | |
| RU95105249A (ru) | Гидрохлорид ng монометил-l-аргинина, способы его получения, способ получения фармацевтического препарата и способ лечения | |
| RU95104171A (ru) | Средство для лечения иммуносупрессии при сепсисе у человека и способ ее лечения | |
| PL315619A1 (en) | Oral form of a drug containing acid active substances and method of obtaining same | |
| RU94046312A (ru) | Применение биологически активных уреидопроизводных для лечения индуцируемых лентивирусами заболеваний, продукты, содержащие уреидопроизводные | |
| DE69321096D1 (de) | Katecholamine-diphosphate und diese enthaltende arzneimittel | |
| RU94045008A (ru) | Способ преодоления гематоэнцефалического барьера | |
| RU95105590A (ru) | Гепатотропные конъюгаты антивирусных лекарственных средств, их носители, содержащие их фармацевтические композиции, способ получения конъюгатов |